Jaguar Health Inc. (JAGX)
NASDAQ: JAGX
· Real-Time Price · USD
4.07
0.17 (4.36%)
At close: Jun 06, 2025, 3:59 PM
4.06
-0.25%
After-hours: Jun 06, 2025, 05:55 PM EDT
Jaguar Health Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| License Revenue | 129K | 9.6M | 11.7M | 3.3M | 9.3M | 5.67M | 4.12M | 344.19K |
| License Revenue Growth | -98.66% | -17.95% | +254.55% | -64.52% | +63.93% | +37.63% | +1097.56% | n/a |
| Mytesi Revenue | 11.3M | 42K | 48K | 62K | 76K | 102.19K | 116.84K | 1.06M |
| Mytesi Revenue Growth | +26804.76% | -12.50% | -22.58% | -18.42% | -25.63% | -12.54% | -89.01% | n/a |
| Neonorm Revenue | 28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Neonorm Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7.39M | 6.58M | 5.79M | 5.84M | 5.21M | 4.75M | 5M | 6.01M | 6.7M | 4.74M | 6.49M | 6.49M | 8.98M | 6.95M | 6.23M | 7.26M | 5.55M | 5.05M | 5.84M | 5.49M | 4.62M | 5.19M | 4.81M | 5.37M | 5.08M | 6.23M | 5.42M | 5.75M | 4.71M | 4.88M | 3.73M | 2.3M | 3.43M | 1.79M | 1.25M | 1.47M | 1.95M | 1.8M | 1.56M | 1.46M | 1.28M |
| Selling, General, and Administrative Revenue Growth | +12.40% | +13.64% | -0.89% | +11.97% | +9.88% | -5.19% | -16.72% | -10.26% | +41.29% | -27.00% | 0.00% | -27.69% | +29.18% | +11.57% | -14.18% | +30.84% | +9.86% | -13.56% | +6.49% | +18.80% | -10.94% | +7.92% | -10.52% | +5.74% | -18.45% | +14.90% | -5.73% | +22.07% | -3.38% | +30.55% | +62.71% | -33.01% | +91.06% | +43.25% | -14.90% | -24.69% | +8.45% | +15.78% | +6.32% | +13.96% | n/a |
| Research and Development Revenue | 3.73M | 4.53M | 4.04M | 3.65M | 4.31M | 3.46M | 6.08M | 4.28M | 4.78M | 4.31M | 5.94M | 2.45M | 4.95M | 5.48M | 3.31M | 3.87M | 2.41M | 1.9M | 1.52M | 1.41M | 1.58M | 1.39M | 1.31M | 1.7M | 1.42M | 1.31M | 1.48M | 1.6M | 757.87K | 1.24M | 851.61K | 926.79K | 1.26M | 1.53M | 1.97M | 1.95M | 1.75M | 2.06M | 1.24M | 1.75M | 1.42M |
| Research and Development Revenue Growth | -17.73% | +12.14% | +10.68% | -15.28% | +24.52% | -43.05% | +42.18% | -10.43% | +10.76% | -27.42% | +142.35% | -50.43% | -9.80% | +65.52% | -14.42% | +60.31% | +26.79% | +25.10% | +8.33% | -11.19% | +13.53% | +6.59% | -22.99% | +19.44% | +8.43% | -11.50% | -7.71% | +111.76% | -38.66% | +45.09% | -8.11% | -26.18% | -18.18% | -22.00% | +0.69% | +11.53% | -15.03% | +66.29% | -29.20% | +23.07% | n/a |
| Sales and Marketing Revenue | 2.49M | 1.54M | 2.01M | 1.52M | 661K | 1.53M | 637K | 878K | 1.88M | 1.75M | 2.11M | 1.34M | 2.83M | 2.3M | 2.26M | 2.19M | 2.14M | 1.88M | 1.53M | 1.73M | 1.47M | 1.5M | 1.7M | 2.17M | 1.57M | 2.71M | 2.72M | 2.69M | 1.71M | 2.14M | 663.76K | 157.23K | 122.91K | 130.09K | 136.88K | 54.05K | 164.41K | 245.82K | 165.75K | 163.23K | 190.3K |
| Sales and Marketing Revenue Growth | +61.67% | -23.28% | +31.89% | +130.56% | -56.83% | +140.35% | -27.45% | -53.40% | +7.78% | -17.12% | +57.86% | -52.87% | +23.37% | +1.64% | +3.19% | +2.43% | +13.72% | +23.02% | -11.62% | +17.77% | -2.05% | -11.70% | -21.84% | +38.84% | -42.30% | -0.16% | +0.98% | +57.12% | -19.98% | +222.38% | +322.16% | +27.92% | -5.52% | -4.96% | +153.25% | -67.13% | -33.12% | +48.31% | +1.54% | -14.23% | n/a |